Ansell Introduces World's First Antiviral Condom To Canadian Market

LifeStyles® Dual Protect with VivaGel® lubricant launches on

ISELIN, N.J., April 11, 2017 /CNW/ -- Ansell, a global leader in protection solutions and the makers of LifeStyles® and SKYN® Condoms ("SKYN"), announces today the Canada launch of LifeStyles® Dual Protect. The first condom of its kind, Dual Protect features patented VivaGel® lubricant, developed by Starpharma. VivaGel, an innovative antiviral agent, has been proven in laboratory studies to inactivate HIV (human immunodeficiency virus), HSV (herpes simplex virus) and HPV (human papillomavirus).

"At Ansell, safety and innovation have always been at the forefront of our mission, and we pride ourselves on our ability to identify the needs of our consumers and develop innovative products that not only protect users, but enhance the sexual experience," says Jeyan Heper, President and General Manager, Sexual Wellness Global Business Unit at Ansell. "LifeStyles Dual Protect is a great example of this, and by combining a premium latex condom with Starpharma's patented antiviral VivaGel technology, Ansell is proud to introduce this first-of-its-kind condom to Canadian consumers."

According to Canada's Public Health Agency, STI rates have been rising steadily since the late 1990's, further exemplifying the need for a product of this kind. VivaGel (SPL7013, or astodrimer sodium) is antiviral and has been proven in laboratory studies to inactivate up to 99.9% of HIV (human immunodeficiency virus), HSV (herpes simplex virus) and HPV (human papillomavirus), which are viruses that cause STIs. LifeStyles Dual Protect is the only condom of its type, providing barrier protection and incorporating the proprietary antiviral VivaGel in the condom lubricant.

Starpharma Chief Executive Officer, Dr. Jackie Fairley, said, "We are delighted to be working with Ansell, one of the world's leading protection companies, to bring this highly innovative product to the North American market. We look forward to making it available to consumers and to subsequent launches around the world."

Having been granted a medical device license for the VivaGel condom after an intensive approval process by the Canadian regulatory authority, Health Canada, LifeStyles Dual Protect will become available for the first time in Canada via Initially launched in Australia, regulatory reviews continue in a number of geographic regions, with further approvals anticipated for this innovative technology in the coming months.

LifeStyles Dual Protect 10-count packs are available for purchase on  All LifeStyles Condoms are triple tested to meet the highest reliability standards. LifeStyles Condoms are available online in addition to a wide range of big box retailers, drugstores, grocery and convenience stores across North America.

About Ansell
Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being. With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs nearly 15,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well-being category worldwide. Ansell operates in four main business segments: Medical, Industrial, Single Use and Sexual Wellness. Information on Ansell and its products can be found at

Ansell, ® and TM are trademarks owned by Ansell Limited or one of its affiliates. US Patented and US and non-US Patents Pending: © 2017 Ansell Limited. All Rights Reserved.

About Starpharma
Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY), located in Melbourne Australia, is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications.

Starpharma's underlying technology is built around dendrimers – a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses.  Starpharma has three core development programs: VivaGel® portfolio, DEP™ drug delivery, and agrochemicals with the Company developing a number of products internally and others via commercial partnerships. For more information please visit:

SOURCE Ansell Healthcare

For further information:, 212-999-5585,

Organization Profile

Ansell Healthcare

More on this organization

Starpharma Holdings Limited

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890